{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:02:49Z","timestamp":1792789369754,"version":"4.5.0"},"reference-count":274,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A2B5B01002463"],"award-info":[{"award-number":["NRF-2020R1A2B5B01002463"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A6A1A03038996"],"award-info":[{"award-number":["2021R1A6A1A03038996"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease affecting the upper and lower motor neurons, leading to muscle weakness, motor impairments, disabilities and death. Approximately 5\u201310% of ALS cases are associated with positive family history (familial ALS or fALS), whilst the remainder are sporadic (sporadic ALS, sALS). At least 50 genes have been identified as causative or risk factors for ALS. Established pathogenic variants include superoxide dismutase type 1 (SOD1), chromosome 9 open reading frame 72 (c9orf72), TAR DNA Binding Protein (TARDBP), and Fused In Sarcoma (FUS); additional ALS-related genes including Charged Multivesicular Body Protein 2B (CHMP2B), Senataxin (SETX), Sequestosome 1 (SQSTM1), TANK Binding Kinase 1 (TBK1) and NIMA Related Kinase 1 (NEK1), have been identified. Mutations in these genes could impair different mechanisms, including vesicle transport, autophagy, and cytoskeletal or mitochondrial functions. So far, there is no effective therapy against ALS. Thus, early diagnosis and disease risk predictions remain one of the best options against ALS symptomologies. Proteomic biomarkers, microRNAs, and extracellular vehicles (EVs) serve as promising tools for disease diagnosis or progression assessment. These markers are relatively easy to obtain from blood or cerebrospinal fluids and can be used to identify potential genetic causative and risk factors even in the preclinical stage before symptoms appear. In addition, antisense oligonucleotides and RNA gene therapies have successfully been employed against other diseases, such as childhood-onset spinal muscular atrophy (SMA), which could also give hope to ALS patients. Therefore, an effective gene and biomarker panel should be generated for potentially \u201cat risk\u201d individuals to provide timely interventions and better treatment outcomes for ALS patients as soon as possible.<\/jats:p>","DOI":"10.3390\/cells12151948","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T01:56:16Z","timestamp":1690509376000},"page":"1948","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy"],"prefix":"10.3390","volume":"12","author":[{"given":"Eva","family":"Bagyinszky","sequence":"first","affiliation":[{"name":"Graduate School of Environment Department of Industrial and Environmental Engineering, Gachon University, Seongnam-si 13120, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-1488","authenticated-orcid":false,"given":"John","family":"Hulme","sequence":"additional","affiliation":[{"name":"Graduate School of Environment Department of Industrial and Environmental Engineering, Gachon University, Seongnam-si 13120, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Soo A.","family":"An","sequence":"additional","affiliation":[{"name":"Department of Bionano Technology, Gachon University, Seongnam-si 13120, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: A clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_2","first-page":"S320","article-title":"Amyotrophic lateral sclerosis: Disease state overview","volume":"24","author":"Hulisz","year":"2018","journal-title":"Am. J. Manag. Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","article-title":"ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration","volume":"73","author":"Ravits","year":"2009","journal-title":"Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/14660820410021311","article-title":"Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period","volume":"5","author":"Testa","year":"2004","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jnnp.2009.183525","article-title":"Incidence of amyotrophic lateral sclerosis in Europe","volume":"81","author":"Logroscino","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Eurals Consortium Prognostic factors in ALS: A critical review","volume":"10","author":"Chio","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/21678421.2017.1386688","article-title":"Patterns of symptom development in patients with motor neuron disease","volume":"19","author":"Walhout","year":"2018","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/brain\/awr195","article-title":"Motor neuron dysfunction in frontotemporal dementia","volume":"134","author":"Burrell","year":"2011","journal-title":"Brain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnins.2020.00042","article-title":"The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia","volume":"14","author":"Abramzon","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"a024125","DOI":"10.1101\/cshperspect.a024125","article-title":"Genetics of Amyotrophic Lateral Sclerosis","volume":"8","author":"Ghasemi","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jamaneurol.2018.0372","article-title":"Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum","volume":"75","author":"Karch","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/CLEP.S37505","article-title":"Risk factors for amyotrophic lateral sclerosis","volume":"7","author":"Fang","year":"2015","journal-title":"Clin. Epidemiology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1167\/iovs.19-27184","article-title":"Glaucoma-Associated Mutations in the Optineurin Gene Have Limited Impact on Parkin-Dependent Mitophagy","volume":"60","author":"Chernyshova","year":"2019","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Nekoua, M.P., Mercier, A., Alhazmi, A., Sane, F., Alidjinou, E.K., and Hober, D. (2022). Fighting Enteroviral Infections to Prevent Type 1 Diabetes. Microorganisms, 10.","DOI":"10.3390\/microorganisms10040768"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.18632\/oncotarget.27663","article-title":"TAF15 contributes to the radiation-inducible stress response in cancer","volume":"11","author":"Singh","year":"2020","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2016.12.002","article-title":"TAF15\u2013ZNF384 fusion gene in childhood mixed phenotype acute leukemia","volume":"211","author":"Yao","year":"2017","journal-title":"Cancer Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10571-015-0294-3","article-title":"Disease Mechanisms in ALS: Misfolded SOD1 Transferred through Exosome-Dependent and Exosome-Independent Pathways","volume":"36","author":"Silverman","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gene.2015.11.049","article-title":"Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis","volume":"577","author":"Kaur","year":"2016","journal-title":"Gene"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3389\/fneur.2019.00527","article-title":"Structural Properties and Interaction Partners of Familial ALS-Associated SOD1 Mutants","volume":"10","author":"Huai","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"32055","DOI":"10.1074\/jbc.M403590200","article-title":"Superoxide inhibits 4Fe-4S cluster enzymes involved in amino acid biosynthesis. Cross-compartment protection by CuZn-superoxide dismutase","volume":"279","author":"Wallace","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13023-021-01993-0","article-title":"Progressive spastic tetraplegia and axial hypotonia (STAHP) due to SOD1 deficiency: Is it really a new entity?","volume":"16","author":"Pinto","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0960-8966(99)00071-1","article-title":"Amyotrophic lateral sclerosis: Copper\/zinc superoxide dismutase (SOD1) gene mutations","volume":"10","author":"Orrell","year":"2000","journal-title":"Neuromuscul. Disord."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1038\/s41467-022-31240-4","article-title":"Cryo-EM structure of an amyloid fibril formed by full-length human SOD1 reveals its conformational conversion","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/pro.2803","article-title":"Destabilization of the dimer interface is a common consequence of diverse ALS-associated mutations in metal free SOD1","volume":"24","author":"Broom","year":"2015","journal-title":"Protein Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.21319","article-title":"Oxidized\/misfolded superoxide dismutase-1: The cause of all amyotrophic lateral sclerosis?","volume":"62","author":"Kabashi","year":"2007","journal-title":"Ann. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Peggion, C., Scalcon, V., Massimino, M.L., Nies, K., Lopreiato, R., Rigobello, M.P., and Bertoli, A. (2022). SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells. Antioxidants, 11.","DOI":"10.3390\/antiox11040614"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1212\/01.wnl.0000343509.76828.2a","article-title":"Age and founder effect of SOD1 A4V mutation causing ALS","volume":"72","author":"Saeed","year":"2009","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1073\/pnas.0730423100","article-title":"Misfolded CuZnSOD and amyotrophic lateral sclerosis","volume":"100","author":"Valentine","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/21678421.2016.1199698","article-title":"H46R SOD1 mutation is consistently associated with a relatively benign form of amyotrophic lateral sclerosis with slow progression","volume":"17","author":"Zou","year":"2016","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000102170","article-title":"Slowly Progressing Amyotrophic Lateral Sclerosis Caused by H46R SOD1 Mutation","volume":"58","author":"Roos","year":"2007","journal-title":"Eur. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1110\/ps.041256705","article-title":"Structural consequences of the familial amyotrophic lateral sclerosis SOD1 mutant His46Arg","volume":"14","author":"Antonyuk","year":"2005","journal-title":"Protein Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e12604","DOI":"10.1111\/gbb.12604","article-title":"Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1G93A) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes","volume":"19","author":"Kreilaus","year":"2020","journal-title":"Genes Brain Behav."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1089\/ars.2006.8.2075","article-title":"On the relation of oxidative stress to neuroinflammation: Lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis","volume":"8","author":"Hensley","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1515\/hsz-2012-0115","article-title":"TDP-43 in central nervous system development and function: Clues to TDP-43-associated neurodegeneration","volume":"393","author":"Sephton","year":"2012","journal-title":"Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: Integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","article-title":"Protein transmission in neurodegenerative disease","volume":"16","author":"Peng","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tibs.2012.03.003","article-title":"TDP-43: Gumming up neurons through protein-protein and protein-RNA interactions","volume":"37","author":"Buratti","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Wang, P., Deng, J., Dong, J., Liu, J., Bigio, E.H., Mesulam, M., Wang, T., Sun, L., Wang, L., and Lee, A.Y.-L. (2019). TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet., 15.","DOI":"10.1371\/journal.pgen.1007947"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Jiang, L., and Ngo, S.T. (2022). Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis. Metabolites, 12.","DOI":"10.3390\/metabo12080709"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"210160","DOI":"10.1098\/rsos.210160","article-title":"Insights into the aggregation mechanism of RNA recognition motif domains in TDP-43: A theoretical exploration","volume":"8","author":"Liu","year":"2021","journal-title":"R. Soc. Open Sci."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Lim, L., Wei, Y., Lu, Y., and Song, J. (2016). ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43. PLoS Biol., 14.","DOI":"10.1371\/journal.pbio.1002338"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00401-016-1666-6","article-title":"ALS\/FTLD: Experimental models and reality","volume":"133","author":"Tan","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","article-title":"TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity","volume":"284","author":"Johnson","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ensci.2018.04.001","article-title":"TARDBP p.G376D mutation, found in rapid progressive familial ALS, induces mislocalization of TDP-43","volume":"11","author":"Mitsuzawa","year":"2018","journal-title":"Eneurologicalsci"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/humu.22319","article-title":"TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: Summary and update","volume":"34","author":"Lattante","year":"2013","journal-title":"Hum. Mutat."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1093\/hmg\/ddp303","article-title":"Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis","volume":"18","author":"Pesiridis","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Chen, C., Ding, X., Akram, N., Xue, S., and Luo, S.-Z. (2019). Fused in Sarcoma: Properties, Self-Assembly and Correlation with Neurodegenerative Diseases. Molecules, 24.","DOI":"10.3390\/molecules24081622"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40478-020-01111-4","article-title":"Dysfunction in nonsense-mediated decay, protein homeostasis, mitochondrial function, and brain connectivity in ALS-FUS mice with cognitive deficits","volume":"9","author":"Ho","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrneurol.2014.78","article-title":"The role of FUS gene variants in neurodegenerative diseases","volume":"10","author":"Deng","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40478-019-0658-x","article-title":"ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles","volume":"7","author":"An","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainres.2016.03.036","article-title":"Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis","volume":"1647","author":"Shang","year":"2016","journal-title":"Brain Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s13311-015-0338-x","article-title":"TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets","volume":"12","author":"Scotter","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41598-017-00091-1","article-title":"ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation","volume":"7","author":"Sama","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Liu, S., Liu, G., \u00d6zt\u00fcrk, A., and Hicks, G.G. (2013). ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003895"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"E11904","DOI":"10.1073\/pnas.1810413115","article-title":"ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay","volume":"115","author":"Kamelgarn","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/brain\/awp214","article-title":"A new subtype of frontotemporal lobar degeneration with FUS pathology","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2012.01.016","article-title":"The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease","volume":"1462","author":"King","year":"2012","journal-title":"Brain Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"15575","DOI":"10.1038\/s41598-018-33964-0","article-title":"Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity","volume":"8","author":"Nakaya","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jnen\/nlac004","article-title":"Widespread Mislocalization of FUS Is Associated with Mitochondrial Abnormalities in Skeletal Muscle in Amyotrophic Lateral Sclerosis With FUS Mutations","volume":"81","author":"Yu","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"661447","DOI":"10.3389\/fncel.2021.661447","article-title":"C9ORF72: What It Is, What It Does, and Why It Matters","volume":"15","author":"Smeyers","year":"2021","journal-title":"Front Cell Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"Mackenzie","year":"2011","journal-title":"Neuron"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/mp.2015.159","article-title":"The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter","volume":"21","author":"Gijselinck","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/humu.22244","article-title":"European Early-Onset Dementia Consortium. A pan-European study of the C9orf72 repeat associated with FTLD: Geographic prevalence, genomic instability, and intermediate repeats","volume":"34","author":"Gijselinck","year":"2013","journal-title":"Hum. Mutat."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ana.24453","article-title":"C 9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits","volume":"78","author":"Koppers","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.1232927","article-title":"The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS","volume":"339","author":"Mori","year":"2013","journal-title":"Science"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40478-020-01036-y","article-title":"Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity","volume":"8","author":"Quaegebeur","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00401-014-1329-4","article-title":"C9orf72 FTLD\/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration","volume":"128","author":"May","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1126\/science.1256800","article-title":"C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins","volume":"345","author":"Mizielinska","year":"2014","journal-title":"Science"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn.2016.38","article-title":"The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease","volume":"17","author":"Haeusler","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1038\/s41467-018-05273-7","article-title":"A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy","volume":"9","author":"Chitiprolu","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/nn.4604","article-title":"C9orf72 expansion disrupts ATM-mediated chromosomal break repair","volume":"20","author":"Walker","year":"2017","journal-title":"Nat. Neurosci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: A neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"105144","DOI":"10.1016\/j.nbd.2020.105144","article-title":"Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis","volume":"147","author":"Ugbode","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1534-5807(02)00220-4","article-title":"Escrt-III: An endosome-associated heterooligomeric protein complex required for mvb sorting","volume":"3","author":"Babst","year":"2002","journal-title":"Dev. Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e202103033","DOI":"10.1083\/jcb.202103033","article-title":"CHMP2B regulates TDP-43 phosphorylation and cytotoxicity independent of autophagy via CK1","volume":"221","author":"Deng","year":"2022","journal-title":"J. Cell Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"837.e7","DOI":"10.1016\/j.neurobiolaging.2011.10.006","article-title":"VCP mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"33","author":"Koppers","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Ferrari, V., Cristofani, R., Tedesco, B., Crippa, V., Chierichetti, M., Casarotto, E., Cozzi, M., Mina, F., Piccolella, M., and Galbiati, M. (2022). Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23041939"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.neuron.2010.11.040","article-title":"Capturing VCP: Another Molecular Piece in the ALS Jigsaw Puzzle","volume":"68","author":"Shaw","year":"2010","journal-title":"Neuron"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","article-title":"Exome sequencing reveals VCP mutations as a cause of familial ALS","volume":"68","author":"Johnson","year":"2010","journal-title":"Neuron"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Cadoni, M.P.L., Biggio, M.L., Arru, G., Secchi, G., Orr\u00f9, N., Clemente, M.G., Sechi, G., Yamoah, A., Tripathi, P., and Orr\u00f9, S. (2020). VAPB ER-Aggregates, A Possible New Biomarker in ALS Pathology. Cells, 9.","DOI":"10.3390\/cells9010164"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1212\/01.wnl.0000289760.85237.4e","article-title":"New VAPB deletion variant and exclusion of VAPB mutations in familial ALS","volume":"70","author":"Landers","year":"2008","journal-title":"Neurology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/brain\/awr148","article-title":"Distinctive genetic and clinical features of CMT4J: A severe neuropathy caused by mutations in the PI(3,5)P2 phosphatase FIG4","volume":"134","author":"Nicholson","year":"2011","journal-title":"Brain"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/neup.12056","article-title":"ALS-associated protein FIG4 is localized in Pick and Lewy bodies, and also neuronal nuclear inclusions, in polyglutamine and intranuclear inclusion body diseases","volume":"34","author":"Kon","year":"2014","journal-title":"Neuropathology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ejhg.2016.186","article-title":"FIG4 variants in central European patients with amyotrophic lateral sclerosis: A whole-exome and targeted sequencing study","volume":"25","author":"Osmanovic","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1111\/ene.13559","article-title":"New FIG4 gene mutations causing aggressive ALS","volume":"25","author":"Bertolin","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3988\/jcn.2022.18.1.41","article-title":"Novel Variants in the FIG4 Gene Associated with Chinese Sporadic Amyotrophic Lateral Sclerosis with Slow Progression","volume":"18","author":"Liu","year":"2022","journal-title":"J. Clin. Neurol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e1240","DOI":"10.1002\/mgg3.1240","article-title":"Description of combined ARHSP\/JALS phenotype in some patients with SPG11 mutations","volume":"8","author":"Khani","year":"2020","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s42003-019-0615-z","article-title":"Loss of spatacsin impairs cholesterol trafficking and calcium homeostasis","volume":"2","author":"Boutry","year":"2019","journal-title":"Commun. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1093\/hmg\/dds064","article-title":"NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis","volume":"21","author":"Blauw","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"8060","DOI":"10.1074\/jbc.M610314200","article-title":"NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter","volume":"282","author":"Goytain","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1007\/s10072-019-04001-3","article-title":"Analysis of the GCG repeat length in NIPA1 gene in C9orf72-mediated ALS in a large Italian ALS cohort","volume":"40","author":"Corrado","year":"2019","journal-title":"Neurol Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"234.e9","DOI":"10.1016\/j.neurobiolaging.2018.09.012","article-title":"Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort","volume":"74","author":"Tazelaar","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"11253","DOI":"10.1038\/ncomms11253","article-title":"CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"7","author":"Williams","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_96","first-page":"10738584221120182","article-title":"Cyclin F, Neurodegeneration, and the Pathogenesis of ALS\/FTD","volume":"5","author":"Rayner","year":"2022","journal-title":"Neuroscientist"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/hmg\/ddad063","article-title":"ALS-linked CCNF variant disrupts motor neuron ubiquitin homeostasis","volume":"32","author":"Farrawell","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1093\/hmg\/ddz119","article-title":"Pathogenic mutations in the ALS gene CCNF cause cytoplasmic mislocalization of Cyclin F and elevated VCP ATPase activity","volume":"28","author":"Yu","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","article-title":"Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia","volume":"477","author":"Deng","year":"2011","journal-title":"Nature"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Chang, L., and Monteiro, M.J. (2015). Defective Proteasome Delivery of Polyubiquitinated Proteins by Ubiquilin-2 Proteins Containing ALS Mutations. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130162"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e2114051118","DOI":"10.1073\/pnas.2114051118","article-title":"ALS\/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function","volume":"118","author":"Wu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/humu.23062","article-title":"Molecular Chaperones in the Pathogenesis of Amyotrophic Lateral Sclerosis: The Role of HSPB1","volume":"37","author":"Capponi","year":"2016","journal-title":"Hum. Mutat."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.expneurol.2017.08.002","article-title":"HSPB1 mutations causing hereditary neuropathy in humans disrupt non-cell autonomous protection of motor neurons","volume":"297","author":"Heilman","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/15548627.2019.1569930","article-title":"Neuropathy-causing mutations in HSPB1 impair autophagy by disturbing the formation of SQSTM1\/p62 bodies","volume":"15","author":"Haidar","year":"2019","journal-title":"Autophagy"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/humu.9503","article-title":"Genetic variant in the HSPB1 promoter region impairs the HSP27 stress response. Hum Mutat. 2007 Aug;28(8):830","volume":"28","author":"Dierick","year":"2007","journal-title":"Hum Mutat."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cell.2007.10.035","article-title":"Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice","volume":"131","author":"Komatsu","year":"2007","journal-title":"Cell"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/15548627.2016.1170257","article-title":"Defective recognition of LC3B by mutant SQSTM1\/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD","volume":"12","author":"Goode","year":"2016","journal-title":"Autophagy"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/15548627.2019.1644076","article-title":"ALS-FTLD-linked mutations of SQSTM1\/p62 disrupt selective autophagy and NFE2L2\/NRF2 anti-oxidative stress pathway","volume":"16","author":"Deng","year":"2020","journal-title":"Autophagy"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1084\/jem.20161524","article-title":"The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity","volume":"214","author":"Xiao","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e2025053118","DOI":"10.1073\/pnas.2025053118","article-title":"ALS- and FTD-associated missense mutations in TBK1 differentially disrupt mitophagy","volume":"118","author":"Harding","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"24517","DOI":"10.1073\/pnas.1915732116","article-title":"Effects of ALS-associated TANK binding kinase 1 mutations on protein\u2013protein interactions and kinase activity","volume":"116","author":"Ye","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3389\/fimmu.2018.01017","article-title":"Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma","volume":"9","author":"Toth","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1205405","article-title":"Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth","volume":"333","author":"Wild","year":"2011","journal-title":"Science"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1073\/pnas.1523926113","article-title":"Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria","volume":"113","author":"Richter","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1128\/MCB.18.3.1601","article-title":"Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains","volume":"18","author":"Li","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature08971","article-title":"Mutations of optineurin in amyotrophic lateral sclerosis","volume":"465","author":"Maruyama","year":"2010","journal-title":"Nature"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1038\/ncomms5807","article-title":"Dynactin functions as both a dynamic tether and brake during dynein-driven motility","volume":"5","author":"Ayloo","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/WNL.0b013e3181a92c4c","article-title":"Characterization of DCTN1 genetic variability in neurodegeneration","volume":"72","author":"Wider","year":"2009","journal-title":"Neurology"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Deshimaru, M., Kinoshita-Kawada, M., Kubota, K., Watanabe, T., Tanaka, Y., Hirano, S., Ishidate, F., Hiramoto, M., Ishikawa, M., and Uehara, Y. (2021). DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083985"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajhg.2010.12.004","article-title":"NEK1 mutations cause short-rib polydactyly syndrome type majewski","volume":"88","author":"Thiel","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/ng.3626","article-title":"NEK1 variants confer susceptibility to amyotrophic lateral sclerosis","volume":"48","author":"Kenna","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1093\/brain\/aww033","article-title":"NEK1 mutations in familial amyotrophic lateral sclerosis","volume":"139","author":"Brenner","year":"2016","journal-title":"Brain"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature11280","article-title":"Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis","volume":"488","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"E6209","DOI":"10.1073\/pnas.1605964113","article-title":"Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e2024605118","DOI":"10.1073\/pnas.2024605118","article-title":"ALS-linked PFN1 variants exhibit loss and gain of functions in the context of formin-induced actin polymerization","volume":"118","author":"Schmidt","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Teyssou, E., Chartier, L., Roussel, D., Perera, N.D., Nemazanyy, I., Langui, D., Albert, M., Larmonier, T., Saker, S., and Salachas, F. (2022). The Amyotrophic Lateral Sclerosis M114T PFN1 Mutation Deregulates Alternative Autophagy Pathways and Mitochondrial Homeostasis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105694"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Romano, R., Del Fiore, V.S., and Bucci, C. (2022). Role of the Intermediate Filament Protein Peripherin in Health and Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232315416"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"594975","DOI":"10.3389\/fncel.2020.594975","article-title":"The Neglected Genes of ALS: Cytoskeletal Dynamics Impact Synaptic Degeneration in ALS","volume":"14","author":"Chaineau","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"552.e1","DOI":"10.1016\/j.neurobiolaging.2010.02.011","article-title":"A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient","volume":"32","author":"Corrado","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1083\/jcb.200205027","article-title":"A neurotoxic peripherin splice variant in a mouse model of ALS","volume":"160","author":"Robertson","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13041-018-0386-3","article-title":"Dysregulation of human NEFM and NEFH mRNA stability by ALS-linked miRNAs","volume":"11","author":"Hawley","year":"2018","journal-title":"Mol. Brain"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e596","DOI":"10.1212\/NXG.0000000000000596","article-title":"Novel TUBA4A Variant Associated with Familial Frontotemporal Dementia","volume":"7","author":"Mol","year":"2021","journal-title":"Neurol. Genet."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuron.2014.09.027","article-title":"Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS","volume":"84","author":"Smith","year":"2014","journal-title":"Neuron"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuron.2014.10.002","article-title":"Excess of rare damaging TUBA4A variants suggests cytoskeletal defects in ALS","volume":"84","author":"Rademakers","year":"2014","journal-title":"Neuron"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/21678421.2022.2100263","article-title":"A novel mutation in the ALS2 gene in an iranian kurdish family with juvenile amyotrophic lateral sclerosis","volume":"24","author":"Daneshmandpour","year":"2022","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1001\/archneur.60.12.1768","article-title":"Mutation Screening of the ALS2 Gene in Sporadic and Familial Amyotrophic Lateral Sclerosis","volume":"60","author":"Hand","year":"2003","journal-title":"Arch. Neurol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e202007112","DOI":"10.1083\/jcb.202007112","article-title":"ALS2 regulates endosomal trafficking, postsynaptic development, and neuronal survival","volume":"220","author":"Kim","year":"2021","journal-title":"J. Cell Biol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nbd.2006.02.007","article-title":"Senataxin, the yeast Sen1p orthologue: Characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease","volume":"23","author":"Chen","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e01066","DOI":"10.1002\/brb3.1066","article-title":"A novel SETX gene mutation associated with Juvenile amyotrophic lateral sclerosis","volume":"8","author":"Ma","year":"2018","journal-title":"Brain Behav."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"12143","DOI":"10.1038\/ncomms12143","article-title":"Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses","volume":"7","author":"Kapeli","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ajmg.b.31158","article-title":"Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis","volume":"156","author":"Ticozzi","year":"2011","journal-title":"Am. J. Med Genet. Part B Neuropsychiatr. Genet."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1038\/s41598-020-60431-6","article-title":"Loss of angiogenin function is related to earlier ALS onset and a paradoxical increase in ALS duration","volume":"10","author":"Aluri","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"41996","DOI":"10.1038\/srep41996","article-title":"Structural insights into human angiogenin variants implicated in Parkinson\u2019s disease and Amyotrophic Lateral Sclerosis","volume":"7","author":"Bradshaw","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"178.e1","DOI":"10.1016\/j.neurobiolaging.2016.11.010","article-title":"ATXN2 trinucleotide repeat length correlates with risk of ALS","volume":"51","author":"Sproviero","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"key":"ref_146","first-page":"e148363","article-title":"Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation","volume":"6","author":"Beijer","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/neup.12153","article-title":"Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP-43-positive inclusions","volume":"35","author":"Honda","year":"2014","journal-title":"Neuropathology"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/brain\/awy062","article-title":"TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis","volume":"141","author":"Deshaies","year":"2018","journal-title":"Brain"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/brain\/awy091","article-title":"The snowball effect of RNA binding protein dysfunction in amyotrophic lateral sclerosis","volume":"141","author":"Fratta","year":"2018","journal-title":"Brain"},{"key":"ref_150","first-page":"e143948","article-title":"Matrin 3 in neuromuscular disease: Physiology and pathophysiology","volume":"6","author":"Malik","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nn.3688","article-title":"Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis","volume":"17","author":"Johnson","year":"2014","journal-title":"Nat. Neurosci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"14529","DOI":"10.1038\/s41598-017-14924-6","article-title":"ALS Associated Mutations in Matrin 3 Alter Protein-Protein Interactions and Impede mRNA Nuclear Export","volume":"7","author":"Boehringer","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Jankovic, M., Novakovic, I., Dawod, P.G.A., Dawod, A.G.A., Drinic, A., Motaleb, F.I.A., Ducic, S., and Nikolic, D. (2021). Current Concepts on Genetic Aspects of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189832"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/brain\/awu138","article-title":"A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement","volume":"137","author":"Bannwarth","year":"2014","journal-title":"Brain"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41419-022-04602-5","article-title":"CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response","volume":"13","author":"Ruan","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/hmg\/ddab078","article-title":"Multi-OMICS study of a CHCHD10 variant causing ALS demonstrates metabolic rewiring and activation of endoplasmic reticulum and mitochondrial unfolded protein responses","volume":"30","author":"Straub","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-019-01988-z","article-title":"Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10S59L\/+ mouse","volume":"138","author":"Genin","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.nbd.2018.07.027","article-title":"Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases","volume":"119","author":"Genin","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/hmg\/ddx393","article-title":"Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS","volume":"27","author":"Straub","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/hmg\/ddx436","article-title":"CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiency","volume":"27","author":"Brockmann","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jphs.2014.12.012","article-title":"The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis","volume":"127","author":"Fukunaga","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/cdd.2017.88","article-title":"The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins","volume":"24","author":"Dreser","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ajhg.2013.09.008","article-title":"ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19","volume":"93","author":"Takahashi","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"865264","DOI":"10.3389\/fneur.2022.865264","article-title":"Analysis of ERBB4 Variants in Amyotrophic Lateral Sclerosis Within a Chinese Cohort","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"eaax3993","DOI":"10.1126\/scitranslmed.aax3993","article-title":"ANXA11 mutations in ALS cause dysregulation of calcium homeostasis and stress granule dynamics","volume":"12","author":"Nahm","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"886887","DOI":"10.3389\/fneur.2022.886887","article-title":"ANXA11 mutations are associated with amyotrophic lateral sclerosis-frontotemporal dementia","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"fcac299","DOI":"10.1093\/braincomms\/fcac299","article-title":"Clinical and genetic characteristics of amyotrophic lateral sclerosis patients with ANXA11 variants","volume":"4","author":"Sung","year":"2022","journal-title":"Brain Commun."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40035-019-0152-1","article-title":"Loss of CREST leads to neuroinflammatory responses and ALS-like motor defects in mice","volume":"8","author":"Cheng","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fmolb.2018.00008","article-title":"Focus on the Role of D-serine and D-amino Acid Oxidase in Amyotrophic Lateral Sclerosis\/Motor Neuron Disease (ALS)","volume":"5","author":"Kondori","year":"2018","journal-title":"Front. Mol. Biosci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.0914128107","article-title":"Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase","volume":"107","author":"Mitchell","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1093\/hmg\/ddn233","article-title":"Analysis of genome-wide copy number variation in Irish and Dutch ALS populations","volume":"17","author":"Cronin","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jns.2014.02.026","article-title":"SMN1 duplications contribute to sporadic amyotrophic lateral sclerosis susceptibility: Evidence from a meta-analysis","volume":"340","author":"Wang","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1212\/01.wnl.0000233830.85206.1e","article-title":"SMN1 gene, but not SMN2, is a risk factor for sporadic ALS","volume":"67","author":"Corcia","year":"2006","journal-title":"Neurology"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ana.26009","article-title":"The Effect of SMN Gene Dosage on ALS Risk and Disease Severity","volume":"89","author":"Moisse","year":"2021","journal-title":"Ann. Neurol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1474-4422(08)70048-6","article-title":"Copy-number variation in sporadic amyotrophic lateral sclerosis: A genome-wide screen","volume":"7","author":"Blauw","year":"2008","journal-title":"Lancet Neurol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1093\/hmg\/ddq323","article-title":"A large genome scan for rare CNVs in amyotrophic lateral sclerosis","volume":"19","author":"Blauw","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"525097","DOI":"10.1155\/2014\/525097","article-title":"Blood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality?","volume":"2014","author":"Robelin","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00702-012-0806-y","article-title":"CSF markers in amyotrophic lateral sclerosis","volume":"119","author":"Tarasiuk","year":"2012","journal-title":"J. Neural Transm."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Raghunathan, R., Turajane, K., and Wong, L.C. (2022). Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson\u2019s Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169299"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"574133","DOI":"10.3389\/fmolb.2020.574133","article-title":"Metabolomic Biomarkers of Multiple Sclerosis: A Systematic Review","volume":"7","author":"Porter","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"629630","DOI":"10.1155\/2014\/629630","article-title":"Decoding amyotrophic lateral sclerosis: Discovery of novel disease-related biomarkers and future perspectives in neurodegeneration","volume":"2014","author":"Calvo","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000329723","article-title":"Muscle gene expression is a marker of amyotrophic lateral sclerosis severity","volume":"9","author":"Pradat","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3389\/fneur.2020.00919","article-title":"CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression","volume":"11","author":"Sun","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/ene.12421","article-title":"Cerebrospinal fluid neurofilament light chain levels: Marker of progression to generalized amyotrophic lateral sclerosis","volume":"22","author":"Tortelli","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2012.05.018","article-title":"Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and \u03b1-internexin immunoreactivity","volume":"1465","author":"King","year":"2012","journal-title":"Brain Res."},{"key":"ref_187","first-page":"730","article-title":"The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer\u2019s disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta-analysis","volume":"11","author":"Forgrave","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis","volume":"90","author":"Verde","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"753242","DOI":"10.3389\/fnagi.2021.753242","article-title":"Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study","volume":"13","author":"Vacchiano","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"22128","DOI":"10.1038\/s41598-021-01499-6","article-title":"Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics","volume":"11","author":"Behzadi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jnnp-2017-316605","article-title":"Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"89","author":"Jeromin","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp-2014-307672","article-title":"Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: Insights from a longitudinal study","volume":"86","author":"Lu","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.neubiorev.2021.06.027","article-title":"Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact","volume":"127","author":"Munitic","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1038\/s41598-017-09097-1","article-title":"Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: A meta-analysis study","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1212\/NXI.0000000000000244","article-title":"Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis","volume":"3","author":"Lu","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cytogfr.2017.05.001","article-title":"Cytokine expression levels in ALS: A potential link between inflammation and BMAA-triggered protein misfolding","volume":"37","author":"Michaelson","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"552295","DOI":"10.3389\/fneur.2020.552295","article-title":"Plasma Inflammatory Cytokines Are Elevated in ALS","volume":"11","author":"Tortelli","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1017\/cjn.2016.284","article-title":"Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study","volume":"44","author":"Blasco","year":"2017","journal-title":"Can. J. Neurol. Sci.\/J. Can. des Sci. Neurol."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Cao, M.C., Cawston, E.E., Chen, G., Brooks, C., Douwes, J., McLean, D., Graham, E.S., Dragunow, M., and Scotter, E.L. (2022). Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis. BMC Neurol., 22.","DOI":"10.1186\/s12883-022-02730-1"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1468-1331.2008.02405.x","article-title":"Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis","volume":"16","author":"Paladino","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s00415-018-9008-3","article-title":"Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis","volume":"265","author":"Scarafino","year":"2018","journal-title":"J. Neurol."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Kojima, Y., Kasai, T., Noto, Y.-I., Ohmichi, T., Tatebe, H., Kitaoji, T., Tsuji, Y., Kitani-Morii, F., Shinomoto, M., and Allsop, D. (2021). Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260323"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"2791622","DOI":"10.1155\/2023\/2791622","article-title":"Diagnostic Role of Tau Proteins in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis","volume":"2023","author":"Thapa","year":"2023","journal-title":"Acta Neurologica. Scandinavica."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/ene.14409","article-title":"Blood biomarkers and prognosis of amyotrophic lateral sclerosis","volume":"27","author":"Sun","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.24980","article-title":"Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF 72 -associated amyotrophic lateral sclerosis","volume":"82","author":"Gendron","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","article-title":"Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease","volume":"74","author":"Gaiani","year":"2017","journal-title":"JAMA Neurol."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Jamerlan, A.M., Shim, K.H., Youn, Y.C., Teunissen, C., An, S.S.A., Scheltens, P., and Kim, S. (2023). Increased oligomeric TDP-43 in the plasma of Korean frontotemporal dementia patients with semantic dementia. Alzheimer\u2019s Dement.","DOI":"10.1002\/alz.13127"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","article-title":"Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"117","author":"Kasai","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/acn3.51256","article-title":"TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis","volume":"8","author":"Beyer","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_210","first-page":"1338","article-title":"Inflammatory markers in cerebrospinal fluid: Independent prognostic biomarkers in amyotrophic lateral sclerosis?","volume":"90","author":"Gille","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jneuroim.2004.09.015","article-title":"The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis","volume":"159","author":"Demestre","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00702-014-1205-3","article-title":"Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)","volume":"121","author":"Mroczko","year":"2014","journal-title":"J. Neural Transm."},{"key":"ref_213","first-page":"117","article-title":"Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods","volume":"60","author":"Janik","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Irwin, K.E., Jasin, P., Braunstein, K.E., Sinha, I., Bowden, K.D., Moghekar, A., Oh, E.S., Raitcheva, D., Bartlett, D., and Berry, J.D. (2023). A fluid biomarker reveals loss of TDP-43 splicing repression in pre-symptomatic ALS. bioRxiv.","DOI":"10.1101\/2023.01.23.525202"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"eaai7866","DOI":"10.1126\/scitranslmed.aai7866","article-title":"Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72 -associated amyotrophic lateral sclerosis","volume":"9","author":"Gendron","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/s41467-022-30387-4","article-title":"Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS\/FTD","volume":"13","author":"Krishnan","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_217","first-page":"e122768","article-title":"An endogenous peptide marker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1 amyotrophic lateral sclerosis","volume":"4","author":"Gertsman","year":"2019","journal-title":"JCI Investig."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamaneurol.2013.593","article-title":"SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy","volume":"70","author":"Winer","year":"2013","journal-title":"JAMA Neurol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/jnnp-2019-320442","article-title":"CSF chitinase proteins in amyotrophic lateral sclerosis","volume":"90","author":"Thompson","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/jnnp-2017-317138","article-title":"Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression","volume":"89","author":"Steinacker","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2009.02775.x","article-title":"Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"17","author":"Janik","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41591-021-01295-9","article-title":"Altered perivascular fibroblast activity precedes ALS disease onset","volume":"27","author":"Skene","year":"2021","journal-title":"Nat. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fneur.2020.00377","article-title":"The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond","volume":"11","author":"Gaur","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00401-013-1200-z","article-title":"C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci","volume":"126","author":"Mizielinska","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ana.25276","article-title":"Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion","volume":"84","author":"Benatar","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s12017-016-8396-8","article-title":"Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients","volume":"18","author":"Benigni","year":"2016","journal-title":"NeuroMolecular Med."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Barbo, M., and Ravnik-Glava\u010d, M. (2023). Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis. Genes, 14.","DOI":"10.3390\/genes14020325"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"24178","DOI":"10.18632\/oncotarget.4680","article-title":"Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure","volume":"6","author":"Ding","year":"2015","journal-title":"Oncotarget"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13273-014-0014-y","article-title":"Toxicology study with microRNA","volume":"10","author":"An","year":"2014","journal-title":"Mol. Cell. Toxicol."},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Kim, H., Pyo, J.Y., Moon, J., Lee, S., Kim, M., Choi, Y., Shin, D.-I., and Park, B.-G. (2022). Identification of miRNA expression associated with Alzheimer\u2019s disease and neurodegeneration in rat models with obstructive sleep apnea. Mol. Cell. Toxicol.","DOI":"10.1007\/s13273-022-00309-y"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1756-6606-6-26","article-title":"Altered microRNA expression profile in amyotrophic lateral sclerosis: A role in the regulation of NFL mRNA levels","volume":"6","author":"Droppelmann","year":"2013","journal-title":"Mol. Brain"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fnmol.2016.00069","article-title":"Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis","volume":"9","author":"Chen","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neures.2019.10.010","article-title":"Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients","volume":"160","author":"Hayashi","year":"2020","journal-title":"Neurosci. Res."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10048-014-0420-2","article-title":"miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients","volume":"15","author":"Annunziata","year":"2014","journal-title":"Neurogenetics"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41593-021-00936-z","article-title":"Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis","volume":"24","author":"Magen","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2017.03.027","article-title":"Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS)","volume":"55","author":"Waller","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Sproviero, D., Gagliardi, S., Zucca, S., Arigoni, M., Giannini, M., Garofalo, M., Olivero, M., Dell\u2019orco, M., Pansarasa, O., and Bernuzzi, S. (2021). Different miRNA Profiles in Plasma Derived Small and Large Extracellular Vesicles from Patients with Neurodegenerative Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052737"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"120396","DOI":"10.1016\/j.jns.2022.120396","article-title":"miRNA extracted from extracellular vesicles is a robust biomarker of amyotrophic lateral sclerosis","volume":"442","author":"Banack","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"102022","DOI":"10.1016\/j.pneurobio.2021.102022","article-title":"Role of extracellular vesicles in neurodegenerative diseases","volume":"201","author":"Xiao","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"McCluskey, G., Morrison, K.E., Donaghy, C., Rene, F., Duddy, W., and Duguez, S. (2022). Extracellular Vesicles in Amyotrophic Lateral Sclerosis. Life, 13.","DOI":"10.3390\/life13010121"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"785741","DOI":"10.3389\/fnagi.2022.785741","article-title":"Extracellular Vesicles Derived from Plasma of Patients with Neurodegenerative Disease Have Common Transcriptomic Profiling","volume":"14","author":"Sproviero","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7150\/ijbs.79063","article-title":"Extracellular vesicles, the emerging mirrors of brain physiopathology","volume":"19","author":"Cano","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"117070117070","DOI":"10.1016\/j.jns.2020.117070","article-title":"Exosomal TAR DNA-binding protein-43 and neurofilaments in plasma of amyotrophic lateral sclerosis patients: A longitudinal follow-up study","volume":"418","author":"Chen","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13024-021-00470-3","article-title":"Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis","volume":"16","author":"Pasetto","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Pregnolato, F., Cova, L., Doretti, A., Bardelli, D., Silani, V., and Bossolasco, P. (2021). Exosome microRNAs in Amyotrophic Lateral Sclerosis: A Pilot Study. Biomolecules, 11.","DOI":"10.3390\/biom11081220"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3389\/fnins.2019.00574","article-title":"Increased Interleukin-6 Levels in the Astrocyte-Derived Exosomes of Sporadic Amyotrophic Lateral Sclerosis Patients","volume":"13","author":"Chen","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"120156","DOI":"10.1016\/j.lfs.2021.120156","article-title":"The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder","volume":"288","author":"Dhasmana","year":"2022","journal-title":"Life Sci."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp-2013-305726","article-title":"A roadmap for genetic testing in ALS","volume":"85","author":"Traynor","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/jnnp-2013-305546","article-title":"Genetic counselling in ALS: Facts, uncertainties and clinical suggestions","volume":"85","author":"Battistini","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/WCO.0000000000001094","article-title":"Biomarkers for amyotrophic lateral sclerosis","volume":"35","author":"Witzel","year":"2022","journal-title":"Curr. Opin. Neurol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1007\/s12035-017-0537-z","article-title":"MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis","volume":"55","author":"Rinchetti","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Liu, J., Zhou, F., Guan, Y., Meng, F., Zhao, Z., Su, Q., Bao, W., Wang, X., Zhao, J., and Huo, Z. (2022). The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis. Cells, 11.","DOI":"10.3390\/cells11030572"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/mus.26801","article-title":"Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS","volume":"62","author":"Goyal","year":"2020","journal-title":"Muscle Nerve"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.2174\/092986707782793862","article-title":"The Heterogeneity of Amyotrophic Lateral Sclerosis: A Possible Explanation of Treatment Failure","volume":"14","author":"Beghi","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1038\/s41598-019-40632-4","article-title":"Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral Sclerosis","volume":"9","author":"Leoni","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/ane.13698","article-title":"Blood biomarkers in ALS: Challenges, applications and novel frontiers","volume":"146","author":"Sturmey","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41598-018-36873-4","article-title":"Stratification of amyotrophic lateral sclerosis patients: A crowdsourcing approach","volume":"9","author":"Kueffner","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13273-014-0001-3","article-title":"Nanoparticles for gene delivery: Therapeutic and toxic effects","volume":"10","author":"Choi","year":"2014","journal-title":"Mol. Cell. Toxicol."},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Lejman, J., Panuciak, K., Nowicka, E., Mastalerczyk, A., Wojciechowska, K., and Lejman, M. (2023). Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021130"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"New Engl. J. Med."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s13311-022-01237-4","article-title":"Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: The ATLAS Study","volume":"19","author":"Benatar","year":"2022","journal-title":"Neurotherapeutics"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41467-021-21112-8","article-title":"Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"e669","DOI":"10.1212\/NXG.0000000000000669","article-title":"Progress in Amyotrophic Lateral Sclerosis Gene Discovery: Reflecting on Classic Approaches and Leveraging Emerging Technologies","volume":"8","author":"Smukowski","year":"2022","journal-title":"Neurol. Genet."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2003715","article-title":"Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS","volume":"383","author":"Miller","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_265","doi-asserted-by":"crossref","unstructured":"Arnold, C. (2019). Custom therapies pose huge financial burdens. Nat. Med.","DOI":"10.1038\/d41591-019-00021-w"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ana.24618","article-title":"Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model","volume":"79","author":"Stoica","year":"2016","journal-title":"Ann. Neurol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMoa2005056","article-title":"SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS","volume":"383","author":"Mueller","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"Fang, T., Je, G., Pacut, P., Keyhanian, K., Gao, J., and Ghasemi, M. (2022). Gene Therapy in Amyotrophic Lateral Sclerosis. Cells, 11.","DOI":"10.3390\/cells11132066"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.001","article-title":"Targeting RNA-Mediated Toxicity in C9orf72 ALS and\/or FTD by RNAi-Based Gene Therapy","volume":"16","author":"Martier","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.omtn.2019.01.010","article-title":"Artificial MicroRNAs Targeting C9orf72 Can Reduce Accumulation of Intra-nuclear Transcripts in ALS and FTD Patients","volume":"14","author":"Martier","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1212\/WNL.0b013e31826e9b1d","article-title":"Presymptomatic studies in ALS: Rationale, challenges, and approach","volume":"79","author":"Benatar","year":"2012","journal-title":"Neurology"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/21678421.2019.1587634","article-title":"Defining pre-symptomatic amyotrophic lateral sclerosis","volume":"20","author":"Benatar","year":"2019","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neurol.2019.07.027","article-title":"Pre-symptomatic diagnosis in ALS","volume":"176","author":"Corcia","year":"2020","journal-title":"Rev. Neurol."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/awab404","article-title":"Preventing amyotrophic lateral sclerosis: Insights from pre-symptomatic neurodegenerative diseases","volume":"145","author":"Benatar","year":"2022","journal-title":"Brain"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/15\/1948\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:20:27Z","timestamp":1760127627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/15\/1948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":274,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["cells12151948"],"URL":"https:\/\/doi.org\/10.3390\/cells12151948","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]}}}